These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 30551372)

  • 1. Comparison of effects of MHBFC on cardiac hypertrophy after banding of the abdominal aorta in wild-type mice and eNOS knockout mice.
    He J; Ye F; Tang X; Wei J; Xie J; Wu X; Wei X; Xu X; Huang R; Huang J
    Biomed Pharmacother; 2019 Jan; 109():1221-1232. PubMed ID: 30551372
    [No Abstract]   [Full Text] [Related]  

  • 2. The regulatory mechanisms of Yulangsan MHBFC reversing cardiac remodeling in rats based on eNOS-NO signaling pathway.
    Ye F; He J; Wu X; Xie J; Chen H; Tang X; Lai Z; Huang R; Huang J
    Biomed Pharmacother; 2019 Sep; 117():109141. PubMed ID: 31228800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone on the pressure overload-induced progression of cardiac hypertrophy to cardiac failure.
    Huang J; Tang X; Liang X; Wen Q; Zhang S; Xuan F; Jian J; Lin X; Huang R
    PLoS One; 2014; 9(3):e91834. PubMed ID: 24622486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
    Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ
    J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on Pressure Overload-Induced Cardiac Remodeling in Rats and the Endothelial Mechanisms Based on PGI2.
    Huang J; Tang X; Liang X; Wen Q; Zhang S; Xuan F; Jian J; Lin X; Huang R
    Cell Physiol Biochem; 2015; 36(3):1004-14. PubMed ID: 26112123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis.
    Kazakov A; Müller P; Jagoda P; Semenov A; Böhm M; Laufs U
    Cardiovasc Res; 2012 Mar; 93(3):397-405. PubMed ID: 22106415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overload.
    van Deel ED; Octavia Y; de Boer M; Juni RP; Tempel D; van Haperen R; de Crom R; Moens AL; Merkus D; Duncker DJ
    J Mol Cell Cardiol; 2015 Nov; 88():145-54. PubMed ID: 26436984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 17-methoxyl-7-hydroxy-benzene-furanchalcone isolated from Millettia pulchra on myocardial ischemia in vitro and in vivo.
    Jian J; Qing F; Zhang S; Huang J; Huang R
    Planta Med; 2012 Aug; 78(12):1324-31. PubMed ID: 22700048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice.
    Godo S; Sawada A; Saito H; Ikeda S; Enkhjargal B; Suzuki K; Tanaka S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):97-107. PubMed ID: 26543099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
    Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
    Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine study of portal hypertension associated endothelin-1 hypo-response.
    Theodorakis N; Maluccio M; Skill N
    World J Gastroenterol; 2015 Apr; 21(16):4817-28. PubMed ID: 25944995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
    Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
    World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats.
    Yang J; Chen YN; Xu ZX; Mou Y; Zheng LR
    Cell Physiol Biochem; 2016; 39(1):229-41. PubMed ID: 27336844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AVE 3085, a novel endothelial nitric oxide synthase enhancer, attenuates cardiac remodeling in mice through the Smad signaling pathway.
    Chen Y; Chen C; Feng C; Tang A; Ma Y; He X; Li Y; He J; Dong Y
    Arch Biochem Biophys; 2015 Mar; 570():8-13. PubMed ID: 25712222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression.
    Flaherty MP; Brown M; Grupp IL; Schultz JE; Murphree SS; Jones WK
    Cardiovasc Toxicol; 2007; 7(3):165-77. PubMed ID: 17901560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
    Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
    Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
    Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.